ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,011,290,000 | -29.4% | 74,500 | +7.9% | 0.40% | -28.4% |
| Q4 2014 | $4,263,147,000 | +12.7% | 69,050 | -29.1% | 0.55% | +4.2% |
| Q3 2014 | $3,783,984,000 | +593.0% | 97,450 | +514.8% | 0.53% | +616.2% |
| Q2 2014 | $546,033,000 | -57.2% | 15,850 | -46.4% | 0.07% | -57.5% |
| Q1 2014 | $1,276,856,000 | +0.6% | 29,550 | -7.2% | 0.17% | -10.3% |
| Q4 2013 | $1,268,904,000 | +3.5% | 31,850 | -2.5% | 0.19% | -3.0% |
| Q3 2013 | $1,225,681,000 | +33.6% | 32,650 | -4.4% | 0.20% | +27.4% |
| Q2 2013 | $917,610,000 | – | 34,150 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |